Wells Fargo’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,061
| Closed | -$66.1K | – | 7865 |
|
|
2022
Q4 | $66.1K | Buy |
3,061
+21
| +0.7% | +$444 | ﹤0.01% | 4739 |
|
|
2022
Q3 | $59K | Buy |
3,040
+628
| +26% | +$13K | ﹤0.01% | 4877 |
|
|
2022
Q2 | $49K | Sell |
2,412
-1,526
| -39% | -$40.3K | ﹤0.01% | 5033 |
|
|
2022
Q1 | $117K | Sell |
3,938
-6,001
| -60% | -$176K | ﹤0.01% | 5245 |
|
|
2021
Q4 | $231K | Buy |
9,939
+6,399
| +181% | +$170K | ﹤0.01% | 5189 |
|
|
2021
Q3 | $110K | Buy |
3,540
+3,236
| +1,064% | +$100K | ﹤0.01% | 5354 |
|
|
2021
Q2 | $11K | Sell |
304
-15,238
| -98% | -$495K | ﹤0.01% | 6126 |
|
|
2021
Q1 | $548K | Sell |
15,542
-25,919
| -63% | -$957K | ﹤0.01% | 4635 |
|
|
2020
Q4 | $1.55M | Buy |
41,461
+10,428
| +34% | +$379K | ﹤0.01% | 3672 |
|
|
2020
Q3 | $1.04M | Sell |
31,033
-1,309
| -4% | -$38.1K | ﹤0.01% | 3835 |
|
|
2020
Q2 | $857K | Buy |
32,342
+23,755
| +277% | +$560K | ﹤0.01% | 3932 |
|
|
2020
Q1 | $141K | Sell |
8,587
-4,836
| -36% | -$106K | ﹤0.01% | 4889 |
|
|
2019
Q4 | $341K | Sell |
13,423
-5,565
| -29% | -$111K | ﹤0.01% | 4653 |
|
|
2019
Q3 | $379K | Buy |
18,988
+828
| +5% | +$21.4K | ﹤0.01% | 4561 |
|
|
2019
Q2 | $585K | Buy |
18,160
+5,192
| +40% | +$174K | ﹤0.01% | 4272 |
|
|
2019
Q1 | $418K | Buy |
12,968
+317
| +3% | +$8.53K | ﹤0.01% | 4444 |
|
|
2018
Q4 | $311K | Buy |
12,651
+7,975
| +171% | +$211K | ﹤0.01% | 4644 |
|
|
2018
Q3 | $154K | Buy |
4,676
+3,550
| +315% | +$116K | ﹤0.01% | 5147 |
|
|
2018
Q2 | $40K | Sell |
1,126
-4,997
| -82% | -$162K | ﹤0.01% | 5655 |
|
|
2018
Q1 | $200K | Sell |
6,123
-227
| -4% | -$7.64K | ﹤0.01% | 4990 |
|
|
2017
Q4 | $162K | Buy |
6,350
+4,688
| +282% | +$119K | ﹤0.01% | 5068 |
|
|
2017
Q3 | $35K | Buy |
+1,662
| New | +$39.6K | ﹤0.01% | 5575 |
|
|
2017
Q2 | – | Sell |
-8
| Closed | – | – | 6526 |
|
|
2017
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 6590 |
|
|
2016
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 6516 |
|
|
2016
Q3 | $0 | Buy |
+8
| New | +$94 | ﹤0.01% | 6411 |
|
|
2015
Q3 | – | Sell |
-167
| Closed | -$5K | – | 6530 |
|
|
2015
Q2 | $5K | Buy |
+167
| New | +$5.61K | ﹤0.01% | 6031 |
|
|
2014
Q4 | – | Sell |
-46
| Closed | -$2K | – | 6481 |
|
|
2014
Q3 | $2K | Buy |
+46
| New | +$2.64K | ﹤0.01% | 6012 |
|
|
2014
Q1 | – | Sell |
-17
| Closed | -$1K | – | 6140 |
|
|
2013
Q4 | $1K | Hold |
17
| – | – | ﹤0.01% | 5648 |
|
|
2013
Q3 | $2K | Hold |
17
| – | – | ﹤0.01% | 5465 |
|
|
2013
Q2 | $2K | Buy |
+17
| New | +$1.77K | ﹤0.01% | 5398 |
|
Other funds holding ALBO
Wells Fargo's ALBO Position: Q1 2023 in Review
Wells Fargo sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 3,061 shares — an estimated $66.1K sold.
Wells Fargo first reported a position in ALBO in Q2 2013 and held it in 30 quarters. The position peaked at $1.55M in Q4 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- Wells Fargo reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- Wells Fargo sold 3,061 Albireo Pharma Inc shares in Q1 2023, an estimated $66.1K.
- Wells Fargo first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 30 quarters.
- Wells Fargo's Albireo Pharma Inc position peaked at $1.55M in Q4 2020.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on Wells Fargo's 13F filing for Q1 2023, filed 12 May 2023.